Black race may be associated with worse overall survival in renal cell carcinoma patients.

To examine socio-demographic and treatment variables in an attempt to identify factors associated with survival differences between black and white patients with renal cell carcinoma (RCC).

We identified 79,618 white and 10,604 black patients diagnosed with RCC in the National Cancer Database. We compared the distribution of socio-demographic, presentation and treatment variables between Blacks and Whites and then utilized a multivariable cox proportion hazards regression model to evaluate the contribution of differences in these variables to disparities in overall survival (OS).

Black patients were younger (60 vs. 63 years, P< 0.001) and with a lower stage (12.0% vs. 18.8% Stage III-IV P< 0.001). Blacks presented with a higher Charlson-Deyo score (P< 0.001), lower income (P< 0.001), lower education (P< 0.001) and were less likely to receive radical nephrectomy and systemic therapy for stage IV RCC (29.9% vs. 38.8%, P< 0.001). Unadjusted OS was lower for Whites (5-year survival 79% for Blacks and 77% for Whites). However, OS was lower for Blacks when adjusted for all variables (5-year survival 89% for Blacks and 93% for Whites). On multivariable analysis, black race was independently associated with worse OS, HR: 1.09 (95% confidence interval: 1.03, 1.14, P= 0.002). A sensitivity analysis including patients with complete data on tumor grade confirmed our results.

Our study indicates that black patients present at a younger age and with lower stage RCC, but have worse OS. Blacks experienced disparities in socio-demographic characteristics, clinical presentation, treatment-related factors, and had an independently increased hazard of death.

Urologic oncology. 2020 Sep 16 [Epub ahead of print]

Harry Anastos, Alberto Martini, Nikhil Waingankar, David J Paulucci, Alp Tuna Beksac, Jorge Daza, Hiren V Patel, Greg E Gin, John P Sfakianos, Ketan K Badani

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY., Division of Urologic Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson, Medical School, New Brunswick, NJ., Department of Urology, VA Long Beach Healthcare System, Long Beach, CA., Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: .